Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Viracta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
-
Key Tronic Corporation Announces Results For the Third Quarter of Fiscal Year 2024
-
scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024
-
Weyco Reports First Quarter Sales and Earnings
-
Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
-
Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14
-
Treace Medical Concepts Reports First Quarter 2024 Financial Results
-
Comscore Reports First Quarter 2024 Results
-
The RealReal Announces First Quarter 2024 Results
-
Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
-
Lesaka to acquire leading payment platform Adumo welcoming new shareholders Apis and ARC
-
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
-
A-Mark Precious Metals Reports Fiscal Third Quarter 2024 Results
-
Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates
-
Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024
-
Vigil Neuroscience Reports First Quarter 2024 Financial Results and Provides Business Update
-
ODDITY Tech Reports Record First Quarter Results, Raises Outlook
-
ICU Medical Announces First Quarter 2024 Results
-
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
-
Inuvo Reports 44% Year-Over-Year Revenue Growth to $17.0 Million for the First Quarter of 2024
-
Nature’s Sunshine Reports Strong First Quarter 2024 Results
-
Synchronoss Technologies Reports First Quarter 2024 Results
-
InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2024
-
EverQuote to Participate in Upcoming Investor Conferences
-
SIGA Reports Financial Results for Three Months Ended March 31, 2024
-
Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA
-
Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2024
-
Goodness Growth Holdings Announces First Quarter 2024 Results
-
ClearPoint Neuro Reports First Quarter 2024 Results
-
Veeco Reports First Quarter 2024 Financial Results
-
Latham Group, Inc. Reports First Quarter 2024 Financial Results
-
Intapp Announces Third Quarter Fiscal Year 2024 Financial Results
-
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
-
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
-
The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit
-
ResMed Announces Participation in the RBCCM Global Healthcare Conference
-
GDRX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Case
-
Lyell Immunopharma to Participate in BofA Securities Health Care Conference
-
Oculis Publishes Invitation to the Annual General Meeting
-
TPI Composites Partners with University of Maine and Oak Ridge National Laboratory to Leverage One of the World’s Largest Polymer 3D Printers for Wind Turbine Tooling
-
MARTEN TRANSPORT DECLARES QUARTERLY DIVIDEND
-
Inspire Medical Systems, Inc. Announces First Quarter 2024 Financial Results and Updates 2024 Outlook
-
LegalZoom Reports First Quarter 2024 Financial Results
-
Mercury Systems Reports Third Quarter Fiscal 2024 Results
-
Conifer Holdings Schedules First Quarter 2024 Earnings Conference Call/Webcast for May 15, 2024
-
TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
-
Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
-
United Fire Group, Inc. Reports First Quarter 2024 Results
-
ARKO Corp. Reports First Quarter 2024 Results
-
Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

